Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Alliance
-
-
Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
-
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
-
Capecitabine in Treating Patients With Malignant Mesothelioma
-
Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
-
Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease
-
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
-
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
-
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
-
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Categories
Alliance Committee
Browse by Year